
U.S. Transthyretin Amyloidosis Market Projected To Witness Substantial Growth, 2025-2032:Alnylam Pharmaceuticals, Pfizer
BURLINGAME, CA, UNITED STATES, March 10, 2025 /EINPresswire.com/ -- The Global U.S. Transthyretin Amyloidosis Treatment Market is expected to grow at CAGR 9.7%from 2025 to 2032. The Latest comprehensive Research Report on the U.S. …